Abacavir
Severe
Database
Drug interaction classified as: synergy
Source: DDInter
Drug reference
teriflunomide
Pyrimidine-synthesis inhibitor · Immunomodulator
Pyrimidine-synthesis inhibitorImmunomodulator
CDSCO approved
EXCRETION
—
not curated
INTERACTIONS
12 major
SEVERE in our sources
PREGNANCY
—
not curated
Top interactionssee all 12 →
- AbacavirSevereDatabaseDDInter
- AbataceptSevereDatabaseDDInter
- AbemaciclibSevereDatabaseDDInter
- AbirateroneSevereDatabaseDDInter
Mechanism
Reduces pyrimidine synthesis by reversibly inhibiting dihydro-orotate dehydrogenase, thereby causing a reduction in proliferation of activated B and T cells.
Indications
relapsing-remitting ms
Side effects
Serious
- hepatotoxicity
Drug interactions
Abatacept
Severe
Database
Drug interaction classified as: others
Source: DDInter
Abemaciclib
Severe
Database
Drug interaction classified as: synergy
Source: DDInter
Abiraterone
Severe
Database
Drug interaction classified as: synergy
Source: DDInter
Acalabrutinib
Severe
Database
Drug interaction classified as: synergy
Source: DDInter
Acarbose
Severe
Database
Drug interaction classified as: synergy
Source: DDInter
Acitretin
Severe
Database
Drug interaction classified as: synergy
Source: DDInter
Adalimumab
Severe
Database
Drug interaction classified as: others
Source: DDInter
Afatinib
Severe
Database
Drug interaction classified as: synergy
Source: DDInter
Aflibercept
Severe
Database
Drug interaction classified as: synergy
Source: DDInter
Aldesleukin
Severe
Database
Drug interaction classified as: synergy
Source: DDInter
Alectinib
Severe
Database
Drug interaction classified as: synergy
Source: DDInter
Related guidelines
Ask House about teriflunomide
Continue into a citation-backed clinical answer with the drug context already attached.
Sources: Goodman & Gilman 14e·Verified: 2026-05-10 · House clinical team